Filing Flows

Filing Flows › Edwards Lifesciences (EW) › Recalls, complaints & regulation

Edwards Lifesciences (EW): recalls, EPA violations, clinical trials and Federal Register

Edwards Lifesciences (EW) beyond its filings: 1 recall in the last 12 months (21 in five years, 6 Class I); 0 EPA-regulated facilities in violation, $500K in penalties over five years; 3 Federal Register documents in a year; 45 active clinical trials.

Latest recalls

Edwards Lifesciences' latest quarter

Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.

Questions

Has Edwards Lifesciences had any recalls?

21 recalls on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.

Has Edwards Lifesciences been fined by the EPA?

The 17 EPA-regulated facilities on file under its name drew $500K in penalties over five years; 0 are in violation now.

How many clinical trials does Edwards Lifesciences have?

45 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.